🔖
Cite This Article
KARAKAYA, İ., KÖROĞLU, A. (2022). Cannabinoid Hyperemesis Syndrome due to Synthetic Cannabinoids. Anadolu Psikiyatri Dergisi, Cilt: 18 - Sayı: 1, 93–93. https://ajindex.com/articles/648483
Journals / Anadolu Psikiyatri Dergisi / 2017 / Cilt: 18 - Sayı: 1
Cannabinoid Hyperemesis Syndrome due to Synthetic Cannabinoids
- Journal
- Anadolu Psikiyatri Dergisi
- Pages
- 93–93
- Publication Date
- 2022-11-04
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (7)
- Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006; 58:389-462
- Lambert DM, Fowler CJ. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem 2005; 48:5059-87
- Evren C, Bozkurt M. Sentetik kannabinoidler: Son yılların krizi. Düşünen Adam 2013; 26(1):1-11
- Hopkins CY, Gilchrist BLY. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids. J Emerg Med 2013;45(4):544-546
- Allen JH, De Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004; 53:1566-70
- Sontineni SP, Chaudhary S, Sontineni V, Lanspa SJ. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol 2009; 15:1264-6
- Simonetto DA Oxentenko AS, et al. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012; 87:114-9.